Search Results - "Martínez Badas, María Paz"

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia by González‐López, Tomás José, Pascual, Cristina, Álvarez‐Román, María Teresa, Fernández‐Fuertes, Fernando, Sánchez‐González, Blanca, Caparrós, Isabel, Jarque, Isidro, Mingot‐Castellano, María Eva, Hernández‐Rivas, José Angel, Martín‐Salces, Mónica, Solán, Laura, Beneit, Paola, Jiménez, Reyes, Bernat, Silvia, Andrade, Marcio M., Cortés, Montserrat, Cortti, Maria José, Pérez‐Crespo, Susana, Gómez‐Núñez, Marta, Olivera, Pavel E., Pérez‐Rus, Gloria, Martínez‐Robles, Violeta, Alonso, Rafael, Fernández‐Rodríguez, Angeles, Arratibel, María Carmen, Perera, María, Fernández‐Miñano, Carmen, Fuertes‐Palacio, Miguel Angel, Vázquez‐Paganini, Juan Andrés, Gutierrez‐Jomarrón, Isabel, Valcarce, Inés, de Cabo, Erik, Sainz, Adriana, Fisac, Rosa, Aguilar, Carlos, Paz Martínez‐Badas, María, Peñarrubia, María Jesús, Calbacho, María, de Cos, Carmen, González‐Silva, Manuel, Coria, Erika, Alonso, Arancha, Casaus, Alberto, Luaña, Armando, Galán, Pilar, Fernández‐Canal, Cristina, Garcia‐Frade, Javier, González‐Porras, José Ramón

“…Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the…”
Get full text

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia by González‐López, Tomás José, Sánchez‐González, Blanca, Jarque, Isidro, Bernat, Silvia, Fernández‐Fuertes, Fernando, Caparrós, Isabel, Soto, Inmaculada, Fernández‐Rodríguez, Angeles, Bolaños, Estefanía, Pérez‐Rus, Gloria, Pascual, Cristina, Hernández‐Rivas, José Angel, López‐Ansoar, Elsa, Gómez‐Nuñez, Marta, Martínez‐Robles, Violeta, Olivera, Pavel, Yera Cobo, Maria, Peñarrubia, María Jesús, Fernández‐Miñano, Carmen, Cabo, Erik, Martínez Badas, María Paz, Perdomo, Germán, García‐Frade, Luis Javier

“…Background Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality…”
Get full text

Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma by Martínez, Carmen, de Haro, Manuel Espeso, Romero, Samuel, Gutiérrez, Antonio, Domingo-Domènech, Eva, González-Rodríguez, Ana P., Zeberio, Izaskun, Martínez-Badas, María Paz, Rodríguez-Izquierdo, Antonia, Carpio, Cecilia, Bastos-Oreiro, Mariana, Hernández-Rivas, José Ángel, Vallansot, Rolando, Kelleher, Nicholas, Díaz-Gálvez, Francisco J., Torrado, Tamara, Pereira, Arturo, García-Sanz, Ramón

“…The AETHERA trial demonstrated that brentuximab vedotin (BV) consolidation after autologous stem cell transplantation (ASCT) in patients with Hodgkin lymphoma…”
Get full text

Management of acquired hemophilia A: results from the Spanish registry by Mingot-Castellano, María-Eva, Pardos-Gea, Josep, Haya, Saturnino, Bastida-Bermejo, José-María, Tàssies, Dolors, Marco-Rico, Ana, Núñez, Ramiro, García-Candel, Faustino, de Mora, María-Carmen Fernández-Sanchez, Soto, Inmaculada, Álvarez-Román, María-Teresa, Asenjo, Susana, Carrasco, Marina, Lluch-García, Rafael, Martín-Antorán, José-Manuel, Rodríguez-Alén, Agustín, Roselló, Elena, Torres-Miñana, Laura, Marcellini-Antonio, Shally, Moretó-Quinana, Ana, Rodríguez-García, José-Antonio, Aguinaco-Culebras, Reyes, Alonso-Escobar, Nieves, Cervero-Santiago, Carlos, Fernández-Mosteirín, Núria, Martínez-Badás, María-Paz, Pérez-Sánchez, Montserrat, Pérez-Montes, Rocío, Rodríguez-González, Ramón, Uribe-Barrientos, Marisol, Caparrós-Miranda, Isabel Socorro, Iglesias-Fernández, Miriam, Baena, Ángela, Rodríguez-López, Manuel, Sebrango-Sandia, Ana, Vázquez-Fernández, Irene, Marco, Pascual

“…The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and…”
Get full text

Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice by González-López, Tomás José, Alvarez-Roman, María Teresa, Pascual, Cristina, Sánchez-González, Blanca, Fernández-Fuentes, Fernando, Pérez-Rus, Gloria, Hernández-Rivas, José Angel, Bernat, Silvia, Cortés, Montserrat, Bastida, José María, Martínez-Robles, Violeta, Fernández-Rodríguez, Angeles, Olivera, Pavel, Bolaños, Estefanía, Alonso, Rafael, Entrena, Laura, Gómez-Nuñez, Marta, Bermejo, Nuria, Martínez-Badas, María Paz, Peñarrubia, María Jesús, Alonso, Arancha, Soto, Inmaculada, Yera Cobo, María, Casaus, Alberto, Caparrós, Isabel, Perera, María, Jiménez Bárcenas, Reyes, Heras, Cecilia, Calbacho, María, Tenorio, Maria, Luaña, Armando, Lopez-Ansoar, Elsa, Hermida, Gerardo, García-Frade, Javier, González-Porras, José Ramón, Sanz, Miguel A.

“…Background: Eltrombopag is an oral thrombopoietin receptor agonist (TPO-RA) drug approved in primary chronic ITP. Lack of clinical trials in secondary ITP…”
Get full text

Use of Eltrombopag after Romiplostim in Primary ITP Patients by González-López, Tomás José, Pascual, Cristina, Álvarez-Román, María Teresa, Fernández-Fuentes, Fernando, Sánchez-González, Blanca, Caparrós, Isabel, Jarque, Isidro, Mingot, María Eva, Hernández-Rivas, José Angel, Martín-Salces, Mónica, Solán, Laura, Beneit, Paola, Jiménez, Reyes, Bernat, Silvia, Andrade, Marcio M., Cortés, Montserrat, Cortti, María José, Pérez-Crespo, Susana, Gómez-Núñez, Marta, Olivera, Pavel E., Pérez-Rus, Gloria, Martínez-Robles, Violeta, Alonso, Rafael, Fernández-Rodríguez, Angeles, Arratibel, María Carmen, Perera, María, Fernández-Miñano, Carmen, Fuertes-Palacio, Miguel Angel, Vázquez-Paganini, Juan Andrés, Juárez-Salcedo, Luis Miguel, Valcarce, Inés, Díaz-Gálvez, Francisco Javier, Sainz, Adriana, Fisac, Rosa, Aguilar, Carlos, Martínez-Badas, María Paz, Peñarrubia, María Jesús, García-Frade, Javier, Calbacho, Maria, de Cos, Carmen, González-Silva, Manuel, Coria, Erika, Alonso, Arancha, Casaus, Alberto, Luaña, Armando, Galán, Pilar, Fernández-Canal, Cristina, González-Porras, José Ramón

“…Background: The trombopoietin receptor agonists (TRAs) romiplostim and eltrombopag are effective and safe in the treatment of chronic immune thrombocytopenia…”
Get full text

Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia by González-López, Tomás José, Pascual, Cristina, Álvarez-Román, María Teresa, Fernández-Fuertes, Fernando, Sánchez-González, Blanca, Caparrós, Isabel, Jarque, Isidro, Mingot, María Eva, Hernández-Rivas, José Ángel, Martín-Salces, Mónica, Solán, Laura, Beneit, Paola, Jiménez, Reyes, Bernat, Silvia, Andrade, Marcio M, Cortés, Montserrat, Cortti, Maria José, Pérez-Crespo, Susana, Gómez-Núñez, Marta, Olivera, Pavel E., Pérez-Rus, Gloria, Martínez-Robles, Violeta, Alonso, Rafael, Fernández-Rodríguez, Angeles, Arratibel, María Carmen, Perera, María, Fernández-Miñano, Carmen, Fuertes-Palacio, Miguel Angel, Vázquez-Paganini, Juan Andrés, Gutierrez-Jomarrón, Isabel, Valcarce, Inés, de Cabo, Erik, Sainz, Adriana, Fisac, Rosa, Aguilar, Carlos, Martínez-Badas, María Paz, Peñarrubia, María Jesús, Garcia-Frade, Javier, Calbacho, María, de Cos, Carmen, González-Silva, Manuel, Coria, Erika, Alonso, Arancha, Casaus, Alberto, Luaña, Armando, Galán, Pilar, Fernández-Canal, Cristina, González-Porras, José Ramón

“…Background: Eltrombopag is effective and safe for treating chronic immune thrombocytopenia (ITP) patients who have not responded to previous therapy…”
Get full text

Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers by Gonzalez-Lopez, Tomas Jose, Fernandez-Fuertes, Fernando, Pascual Izquierdo, Maria Cristina, Caparros, Isabel, Bernat, Silvia, Pastoriza, Carmen, Martínez-Badas, Maria Paz, Olivera, Pável E, Caballero, Gonzalo, Hernandez-Rivas, Jose Angel, Martínez-Carballeira, Daniel, Soto Ortega, Inmaculada, Perez Segura, Gloria, Regalado, Isabel, Sánchez-González, Blanca, Jarque, Isidro, garcia Frade, Luis Javier, Sanz, Miguel A.

“…Background: Successful discontinuation of eltrombopag in certain immune thrombocytopenia (ITP) patients after complete response has already been demonstrated…”
Get full text

Effect of Pregnancy on the Clinical Course of ITP Pregnant Women and Their Newborns. Resuts of a Spanish Case Series of 297 Primary ITP Pregnancies by González-López, Tomás José, Olivera, Pavel, Jarque, Isidro, Bastida, Jose Maria, Bernat, Silvia, Sanchez-Gonzalez, Blanca, Bolaños, Estefanía, Perez-Rus, Gloria, Huerta, Ana R., Fernandez-Fuertes, Fernando, Martinez-Robles, Violeta, Martínez-Badas, Maria Paz, Pérez-Montes, Rocio, Penarrubia Ponce, Maria Jesus, Conesa, Venancio, Bermejo, Nuria, Caballero, Gonzalo, Alvarez Roman, Maria Teresa, Fernandez-Miñano, Carmen, Guerrero, Lucia, Marcellini, Shally, Sierra Pacho, Magdalena, Pardal, Emilia, Pastoriza, Carmen, Lopez Ansoar, Maria Elsa, de Cabo, Erik, Hermida, Gerardo, Sanz, Miguel A.

“…Introduction: Given that there is no large case-series, effect of pregnancy on the course of pre-existing primary immune thrombocytopenia (ITP) patients is…”
Get full text